L3VLUP
ProSign in

UTHR in the 13F filings

United Therapeutics Corp Del · CUSIP 91307C102

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 12 Feb 2025
Managers listing it
14
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q3 2024 and Q4 2024; 10 listed it in both
Shares listed
9,323,121
combined, among listed positions
Reported value
$3.3bn
combined, at the quarter end

Among the 94 comparable managers: 8 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing UTHR in Q4 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

14 of 14 holders

ActionFiling
Wellington Management Group LLP2,463,891$869m0.16%Trimmed-706,95812 Feb 2025 (the filing on sec.gov)
Renaissance Technologies LLC2,089,392$737m1.09%Trimmed-66,00013 Feb 2025 (the filing on sec.gov)
Fidelity (FMR LLC)1,471,405$519munder 0.1%Addedn.a.5 Nov 2026 (the filing on sec.gov)
AQR Capital Management LLC975,444$344m0.44%Added+7,71014 Feb 2025 (the filing on sec.gov)
AllianceBernstein LP709,043$250m0.08%Added+157,36312 Feb 2025 (the filing on sec.gov)
Arrowstreet Capital LP542,445$191m0.15%Trimmed-99,15412 Feb 2025 (the filing on sec.gov)
Janus Henderson Group Ltd468,996$165m0.08%Added+8,57714 Feb 2025 (the filing on sec.gov)
T. Rowe Price Associates Inc397,882$140munder 0.1%Addedn.a.14 Feb 2025 (the filing on sec.gov)
Bridgewater Associates LP107,730$38m0.17%Added+45,97513 Feb 2025 (the filing on sec.gov)
Hudson Bay Capital Management LP70,319$25m0.09%Added+34,81014 Feb 2025 (the filing on sec.gov)
Tudor Investment Corp22,387$7.9munder 0.1%Addedn.a.14 Feb 2025 (the filing on sec.gov)
Freestone Grove Partners LP1,785$630kunder 0.1%Heldn.a.14 Feb 2025 (the filing on sec.gov)
Caxton Associates LLP1,402$495kunder 0.1%Trimmed-3,28414 Feb 2025 (the filing on sec.gov)
Farallon Capital Management LLC1,000$353kunder 0.1%Held014 Feb 2025 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2024 to Q4 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (0)

No new position among listed positions.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
10 in Q3 2024 to 14 in Q2 2026

Tracked managers listing it, at least.

051015202014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
UTHR by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20135$378mn.a.n.a.
Q3 20135$587mn.a.n.a.
Q4 20139$1.1bnn.a.n.a.
Q1 20148$923mn.a.n.a.
Q2 20149$716mn.a.n.a.
Q3 201411$1.1bnn.a.n.a.
Q4 201410$1.2bnn.a.n.a.
Q1 201514$1.6bnn.a.n.a.
Q2 201514$1.6bnn.a.n.a.
Q3 201516$1.3bnn.a.n.a.
Q4 201516$1.6bnn.a.n.a.
Q1 201617$1.1bnn.a.n.a.
Q2 201612$869mn.a.n.a.
Q3 201614$1.0bnn.a.n.a.
Q4 201610$1.1bnn.a.n.a.
Q1 201713$1.1bnn.a.n.a.
Q2 201712$1.2bnn.a.n.a.
Q3 20178$1.1bnn.a.n.a.
Q4 201710$1.4bnn.a.n.a.
Q1 20188$1.0bnn.a.n.a.
Q2 201810$996mn.a.n.a.
Q3 20189$1.1bnn.a.n.a.
Q4 20189$1.0bnn.a.n.a.
Q1 20199$1.1bnn.a.n.a.
Q2 201915$804mn.a.n.a.
Q3 201917$913mn.a.n.a.
Q4 201914$863mn.a.n.a.
Q1 202014$1.2bnn.a.n.a.
Q2 202014$1.4bnn.a.n.a.
Q3 202010$797mn.a.n.a.
Q4 202011$1.2bnn.a.n.a.
Q1 202110$1.4bnn.a.n.a.
Q2 202111$1.5bnn.a.n.a.
Q3 202116$1.5bnn.a.n.a.
Q4 202114$1.9bnn.a.n.a.
Q1 202214$1.7bnn.a.n.a.
Q2 202218$2.3bnn.a.n.a.
Q3 202217$2.2bnn.a.n.a.
Q4 202218$2.9bnn.a.n.a.
Q1 202316$2.5bnn.a.n.a.
Q2 202312$2.5bnn.a.n.a.
Q3 202313$2.4bnn.a.n.a.
Q4 202314$2.3bn86
Q1 202419$2.2bn146
Q2 202414$2.5bn87
Q3 202410$2.9bn64
Q4 202414$3.3bn84
Q1 202514$2.1bn76
Q2 202514$1.9bn95
Q3 202516$2.6bn810
Q4 202514$3.8bn1720
Q1 202618$5.1bn1817
Q2 202614$3.5bn1916

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

UTHR and LLY →UTHR and JNJ →UTHR and VRTX →Choose a stock to compare with UTHR →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own UTHR, latest filings →Back to the 13F Explorer →